Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;36 Suppl 1(Suppl 1):S111-27.
doi: 10.1093/carcin/bgv033. Epub 2015 May 22.

Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions

Affiliations
Review

Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions

Julia Kravchenko et al. Carcinogenesis. 2015 Jun.

Abstract

An increasing number of studies suggest an important role of host immunity as a barrier to tumor formation and progression. Complex mechanisms and multiple pathways are involved in evading innate and adaptive immune responses, with a broad spectrum of chemicals displaying the potential to adversely influence immunosurveillance. The evaluation of the cumulative effects of low-dose exposures from the occupational and natural environment, especially if multiple chemicals target the same gene(s) or pathway(s), is a challenge. We reviewed common environmental chemicals and discussed their potential effects on immunosurveillance. Our overarching objective was to review related signaling pathways influencing immune surveillance such as the pathways involving PI3K/Akt, chemokines, TGF-β, FAK, IGF-1, HIF-1α, IL-6, IL-1α, CTLA-4 and PD-1/PDL-1 could individually or collectively impact immunosurveillance. A number of chemicals that are common in the anthropogenic environment such as fungicides (maneb, fluoxastrobin and pyroclostrobin), herbicides (atrazine), insecticides (pyridaben and azamethiphos), the components of personal care products (triclosan and bisphenol A) and diethylhexylphthalate with pathways critical to tumor immunosurveillance. At this time, these chemicals are not recognized as human carcinogens; however, it is known that they these chemicalscan simultaneously persist in the environment and appear to have some potential interfere with the host immune response, therefore potentially contributing to promotion interacting with of immune evasion mechanisms, and promoting subsequent tumor growth and progression.

PubMed Disclaimer

Similar articles

  • Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.
    Nahta R, Al-Mulla F, Al-Temaimi R, Amedei A, Andrade-Vieira R, Bay SN, Brown DG, Calaf GM, Castellino RC, Cohen-Solal KA, Colacci A, Cruickshanks N, Dent P, Di Fiore R, Forte S, Goldberg GS, Hamid RA, Krishnan H, Laird DW, Lasfar A, Marignani PA, Memeo L, Mondello C, Naus CC, Ponce-Cusi R, Raju J, Roy D, Roy R, Ryan EP, Salem HK, Scovassi AI, Singh N, Vaccari M, Vento R, Vondráček J, Wade M, Woodrick J, Bisson WH. Nahta R, et al. Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S2-18. doi: 10.1093/carcin/bgv028. Carcinogenesis. 2015. PMID: 26106139 Free PMC article. Review.
  • The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.
    Chang RB, Beatty GL. Chang RB, et al. J Leukoc Biol. 2020 Jul;108(1):363-376. doi: 10.1002/JLB.3MIR0320-475R. Epub 2020 Apr 9. J Leukoc Biol. 2020. PMID: 32272502 Free PMC article. Review.
  • TGF-beta: a master switch in tumor immunity.
    Gigante M, Gesualdo L, Ranieri E. Gigante M, et al. Curr Pharm Des. 2012;18(27):4126-34. doi: 10.2174/138161212802430378. Curr Pharm Des. 2012. PMID: 22630082 Review.
  • The effect of environmental chemicals on the tumor microenvironment.
    Casey SC, Vaccari M, Al-Mulla F, Al-Temaimi R, Amedei A, Barcellos-Hoff MH, Brown DG, Chapellier M, Christopher J, Curran CS, Forte S, Hamid RA, Heneberg P, Koch DC, Krishnakumar PK, Laconi E, Maguer-Satta V, Marongiu F, Memeo L, Mondello C, Raju J, Roman J, Roy R, Ryan EP, Ryeom S, Salem HK, Scovassi AI, Singh N, Soucek L, Vermeulen L, Whitfield JR, Woodrick J, Colacci A, Bisson WH, Felsher DW. Casey SC, et al. Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S160-83. doi: 10.1093/carcin/bgv035. Carcinogenesis. 2015. PMID: 26106136 Free PMC article. Review.
  • [The immune system - how does anti-tumor immunity arise ?].
    Sankawa Y. Sankawa Y. Oncol Res Treat. 2014;37 Suppl 4:2-5. doi: 10.1159/000366431. Epub 2014 Sep 30. Oncol Res Treat. 2014. PMID: 25301189 German. No abstract available.

Cited by

References

    1. Hanahan D., et al. (2000) The hallmarks of cancer. Cell, 100, 57–70. - PubMed
    1. Hanahan D., et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646–674. - PubMed
    1. Johnson J.P., et al. (1989) Tumor immunology: Paul Ehrlich’s heritage. Immunol. Today, 10, S35–S37. - PubMed
    1. Decker W.K., et al. (2009) Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley’s legacy revisited. Cytokine Growth Factor Rev., 20, 271–281. - PubMed
    1. Burdick C.G. (1937) William Bradley Coley 1862-1936. Ann. Surg., 105, 152. - PMC - PubMed

Publication types

Substances